Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of MultiStem in moderate to severe ulcerative colitis
2010-022766-27Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2011
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis comparing MultiStem with Placebo (2 arms). Primary endpoint: Incidence and severity of adverse events. Started Nov 2011; status: completed.
02
Drugs
invimestrocel
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2010-022766-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022766-27.